Purpose
to advance O-antigen-based Shigella vaccines with the view to licensure and introduction of a vaccine that will prevent mortality and morbidity from Shigella diarrhea and dystentery among children in LMICs
Grantee
Division
Global Health
Date
SEPTEMBER 2019
Region served
GLOBAL
Committed amount
$3,907,015
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology,
Vaccine Development
Duration (months)
29
Grantee location
Redmond, Washington, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.